A consultant neurologist in Dubai who leads a non-profit organization in the Middle East and North Africa with regards improving awareness and treatment outcomes on stroke has reiterated the need for more dedicated stroke centers across the UAE as studies in the last two years have revealed that over 10,000 cases of the preventable condition have been recorded each year.
At a time when the global coronavirus scourge has affected over 8 million people, the discovery of a cheap drug by scientists in the UK signals a major light at the end of a tunnel of no-escape from the killer disease. Scientists in the UK have discovered that dexamethasone, a cheap steroid, can cut deaths in severely ill coronavirus patients by a third, which British Prime Minister Boris Johnson hailed as the “biggest breakthrough yet”.
Represented by Essad Card Committee, the General Headquarter of Dubai Police, has taken the pledge to sponsor all healthcare and treatment expenses for a former employee and three of his sons who are suffering from chronic diabetes.
If there is one segment of humanity which is living in inhuman conditions and subject to inhuman treatment, it is the migrants. Their condition is pitiful and seems to show no signs of let-up.
The number of total deaths in the UAE due to COVID-19 complications remained 2,302 as the Ministry announced no new deaths due to virus infection.
The Dubai Police treated ten scuba divers suffering from decompression sickness known as ‘the bends’ by placing divers inside a decompression chamber located at the Dubai Police Health Centre.
Queen Elizabeth II has been placed under medical supervision because doctors are "concerned for Her Majesty's health," Buckingham Palace said on Thursday, as members of the royal family urgently travelled to Scotland to be with the 96-year-old monarch.
The UAE has authorised the emergency use of Sotrovimab, a monoclonal antibody, for the treatment of patients aged 12 years or older with mild to moderate COVID-19 disease who are at risk of progression to hospitalisation or death.
Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalisations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial.